VIP (2mg) / BPC-157 (500mcg) × 30 Tablets

This dual-compound peptide formulation combines VIP and BPC-157 — two well-characterized molecules studied for their potential influence on vascular, neurological, and regenerative processes. This blend provides a targeted approach for researchers exploring mechanisms of inflammation control, tissue recovery, and neuroprotective signaling within preclinical models.

Blend Composition (Per Tablet):
VIP – 2mg
BPC-157 – 0.5mg
30 tablets per bottle

Key Characteristics:

• VIP (Vasoactive Intestinal Peptide): Neuropeptide investigated for roles in vasodilation, immune modulation, and neuroprotective activity

• BPC-157: Synthetic peptide fragment studied in models of tissue regeneration, inflammation regulation, and recovery response

• Convenient oral format designed for compound stability and accurate dosing

• Consistent ratios optimized for controlled research protocols

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.